A study published in Molecular Psychiatry followed every child born in Finland in 1987 — all 53,147 of them — from birth through age 33. Researchers tracked who got diagnosed with ADHD before adulthood, then watched what happened to those kids’ health records over the next fifteen years. Of 17 adverse health outcomes tested, five stayed statistically significant even after adjusting for socioeconomic status, education, and the kind of multiple-comparison correction that kills most weak findings. Psychiatry Advisor covered the study on August 19, 2026, and it’s a bigger, more specific dataset than most of what’s circulated about ADHD and long-term health this year.

We wrote about the UK life-expectancy gap study back in May — the one showing ADHD adults die 7 to 9 years earlier, mostly from modifiable lifestyle risk. That study named broad categories: driving, sleep, nutrition, financial stress. This one names five actual diagnoses, with actual relative-risk numbers attached to each. Different kind of data. Worth a separate look.

TL;DR — What the Cohort Found

Condition	Relative Risk (Odds Ratio)	Watch For
Epilepsy	4.65×	New seizure activity, unexplained blackouts — get it checked, don’t wait
Mood disorders	2.46×	Depression, bipolar spectrum symptoms, especially after age 20
Poisoning	2.30×	Medication errors, accidental overdose — dosing systems matter here
Substance abuse disorders	2.27×	Self-medicating untreated symptoms with alcohol or drugs
Neurotic disorders	2.12×	Anxiety, phobias, obsessive-compulsive patterns
Cohort size	53,147 people	Entire 1987 Finnish birth year, tracked to age 33
Childhood ADHD diagnosis rate	0.43% (228 people)	A number that says more about 1990s underdiagnosis than about prevalence

Our take: These aren’t soft correlations. An odds ratio above 2 after adjustment is a real signal. Epilepsy at 4.65× is the one nobody’s talking about, and it should be.

---

What the Finnish Cohort Study Actually Did

Finland has something most countries don’t: a national hospital register that’s been logging inpatient care since 1969 and outpatient care since 1998, tied to a unique personal ID that follows a person for life. That’s what makes this study possible. You can’t build a 53,147-person, 33-year dataset without a health system that already tracks everyone the same way.

Researchers, led by George David Batty at University College London working with Finnish co-author Mika Gissler, pulled every child born in Finland in 1987 and checked hospital records for an ADHD diagnosis recorded before their 18th birthday. Then they tracked those same people’s hospital records from age 19 to 33 — 2005 through 2020 — for 17 different health outcomes, everything from epilepsy to gastrointestinal disease to injuries.

Seventeen outcomes tested. Five survived adjustment. That’s the headline, but the adjustment part matters more than it sounds like it should.

Only 0.43% Were Diagnosed. That’s the Real Story Underneath This One

Two hundred twenty-eight people out of 53,147 got an ADHD diagnosis before turning 18. That’s 0.43%.

Current estimates put childhood ADHD prevalence somewhere around 5-7% globally. So somewhere between roughly 12 and 18 times more kids in that 1987 cohort almost certainly had ADHD than the ones who got diagnosed with it.

This isn’t a knock on 1990s Finnish pediatricians. It’s what ADHD diagnosis looked like everywhere before the diagnostic criteria expanded past “visibly hyperactive boy disrupting a classroom.” We’ve covered this shift before — the surge in adult ADHD diagnoses among men in their 20s and the systematic underdiagnosis that’s only now getting corrected are both downstream of the same 1990s blind spot this cohort was born into.

Which means the 228 people captured in this study are the ones who had it worst, obviously enough, or visibly enough, to get flagged by a doctor in an era that mostly wasn’t looking. The actual effect size in the full undiagnosed population could run in either direction from what’s reported here — worse, if severity tracks with visibility, or more moderate, if the flagged kids were a skewed, high-severity slice. The researchers don’t know. Neither do we. But it’s the caveat to hold onto through everything below.

What Are the 5 Conditions Childhood ADHD Predicts by Age 33?

After adjusting for family socioeconomic status and the study members’ own educational performance, five of the seventeen tested outcomes remained statistically significant:

1. Epilepsy — 4.65 times the risk (95% CI: 1.86–9.75)
2. Mood disorders — 2.46 times the risk (95% CI: 1.50–3.90)
3. Poisoning — 2.30 times the risk (95% CI: 1.02–4.51)
4. Substance abuse disorders — 2.27 times the risk (95% CI: 1.28–3.81)
5. Neurotic disorders — 2.12 times the risk (95% CI: 1.25–3.43)

Adjustment mattered. A lot. The researchers reported that controlling for socioeconomic status and school performance attenuated many of the raw associations by 10% to as much as 63%. Kids with undiagnosed or poorly supported ADHD in the 1990s often ended up in lower-SES households and struggled academically — both of which independently predict worse adult health. Strip that out, and the associations shrink. The five that survived, survived a real filter.

Epilepsy: The One Nobody Frames as an ADHD Risk

4.65× is the largest relative risk in the whole study, and it’s the one least discussed in ADHD content anywhere, including ours until now.

The link isn’t fully explained by this study — it’s an association, not a mechanism — but ADHD and epilepsy share overlapping neurodevelopmental pathways, and stimulant medication interactions with seizure thresholds are a real clinical consideration your prescriber should already be tracking. If you have ADHD and any history of unexplained blackouts, staring spells that aren’t just inattention, or new seizure-like activity, that’s a neurology referral conversation, not something to self-diagnose off a blog post. This is the one condition on this list where “wait and see” isn’t the move.

Mood Disorders: The Predictable One, Confirmed at Scale

2.46× tracks with basically everything else published on ADHD comorbidity. What this cohort adds isn’t surprise — it’s a hard number, from a whole-population dataset, surviving adjustment for the socioeconomic confounds that usually get blamed for inflating this exact association.

We’ve written about the emotional volatility that shows up as rejection sensitive dysphoria in a lot of ADHD adults, and the mechanism connects here directly. Years of unaddressed executive dysfunction, social friction, and the shame spiral that comes with it is a plausible pathway into a diagnosable mood disorder by your 30s — not a certainty, but a documented pattern this study’s numbers back up.

Poisoning: The Vigilance Gap Almost Nobody Names

2.30× risk of poisoning is the outcome most directly addressable with a tool, not a doctor’s visit.

Poisoning events in a hospital register mean acute medication errors, dosing mistakes, and accidental overdoses serious enough for hospital treatment. ADHD’s core deficits — working memory, impulse control, task tracking — are exactly the failure points behind “did I already take that” and “how many did I actually take.” That’s not a moral failing. It’s the same executive function gap that makes to-do lists fall apart, applied to something with actual physical stakes.

If dosing tracking has ever been shaky for you or someone you manage medication for, pill reminder systems built around ADHD failure modes — not generic alarm apps — are the direct countermeasure here.

Substance Abuse Disorders: The Self-Medication Loop, With a Number Attached

2.27× isn’t shocking to anyone who’s spent time in ADHD spaces. What’s useful is having odds-ratio-level confirmation, adjusted for socioeconomic confounds, from a whole national birth cohort rather than a clinical sample that’s already selected for people seeking treatment.

The mechanism most researchers point to is self-medication: untreated ADHD symptoms create real distress, and substances that quiet racing thoughts or provide dopamine the brain isn’t producing enough of on its own become the accessible fix when a diagnosis and prescription aren’t available. We’ve covered the actual neuroscience of how ADHD medication affects motivation and reward circuits — the same reward-seeking wiring that makes stimulant treatment effective is the wiring that makes unregulated substance use appealing when treatment isn’t happening.

Neurotic Disorders: Anxiety, Under a Different Name

2.12× risk of what the ICD classification calls “neurotic disorders” — a category covering anxiety disorders, phobias, and obsessive-compulsive patterns — is the fifth and final significant finding.

We’ve written at length about why ADHD and anxiety systems keep failing each other: anxiety often develops as a compensatory response to years of missed deadlines, forgotten commitments, and the low hum of “what am I forgetting right now” that untreated ADHD produces. This cohort’s number is the population-level version of a pattern that shows up constantly in individual case histories.

Why Only These 5, Out of 17?

Twelve other outcomes — including several physical conditions the researchers tested — didn’t survive adjustment for socioeconomic status, education, and multiple comparisons. That’s not the same as “no risk.” It means the raw association was likely explained by the downstream effects of growing up with unsupported ADHD — lower household income, worse academic outcomes — rather than something more directly tied to ADHD itself.

The five that survived are, in a real sense, the ones the researchers are most confident aren’t just poverty and school struggle wearing an ADHD label. That’s what makes this list worth taking seriously instead of treating as one more scary-sounding ADHD headline.

Our Take

A cohort this size, tracked this long, with this level of statistical rigor, doesn’t come along often. George David Batty and Mika Gissler didn’t set out to alarm anyone — they set out to answer a specific question with data good enough to trust, and the honest answer is that childhood ADHD, even the visibly-severe-enough-to-get-diagnosed-in-1990s-Finland version of it, predicts real, specific, diagnosable conditions fifteen years later.

None of this means these outcomes are inevitable. An odds ratio of 2.46 for mood disorders means the risk is elevated, not that it’s destiny. Most people with childhood ADHD in this cohort did not develop epilepsy, did not develop a substance use disorder, did not end up hospitalized for poisoning.

What it does mean is that “vigilance” isn’t a throwaway word here. If you had ADHD as a kid, or your kid has it now, these five conditions are worth knowing about specifically — not as a source of dread, but as a short list of things to flag early with whoever manages your healthcare, instead of waiting for a crisis to make the connection obvious in hindsight.

---

Sources: Batty, G.D. & Gissler, M., “Pre-adult attention-deficit/hyperactive disorder and later adverse health outcomes: The 1987 Finnish birth cohort study,” Molecular Psychiatry, 2026. Additional reporting via Psychiatry Advisor, Aug. 19, 2026. Full open-access text available via PMC. This post is not medical advice — discuss ADHD-related health risks with a qualified healthcare provider.